Skip to main content
Top
Published in: Journal of Cancer Survivorship 6/2022

04-11-2021 | Review

Large-scale North American cancer survivorship surveys: 2011–2019 update

Authors: Ahrang Jung, Shelley S. Kay, Jennifer L. Robinson, Bonny Bloodgood Sheppard, Deborah K. Mayer

Published in: Journal of Cancer Survivorship | Issue 6/2022

Login to get access

Abstract

Purpose

There are gaps in our knowledge to provide quality cancer care to the growing numbers of survivors. Leveraging existing data to answer survivorship research questions is one approach to address these gaps. Therefore, the purpose of this paper is to replicate and expand a previous report of existing cancer survivorship survey data.

Methods

We conducted a trifold search strategy for relevant surveys and data sets to (1) determine the extent to which cancer survivors are being surveyed, (2) determine the topics being covered in these surveys, and (3) create a compendium of information about these surveys and data sets, so researchers can conduct additional analyses.

Results

Thirty-five surveys were identified and included in this report; most were longitudinal studies (71%) in adult cancer survivors (91%). The domains addressed in these surveys were general medical characteristics, medical conditions, costs, employment, symptoms and/or side effects, psychosocial factors and coping, perceived quality of care, and health behaviors.

Conclusions

Existing data are available for researchers to explore new knowledge to enhance cancer survivorship quality care. This is an opportunity to fully utilize existing data to answer survivorship questions in a cost effective manner.

Implications for Cancer Survivors

Survivors should be encouraged to participate in research studies as these data can close the gap in our knowledge and care of this growing population.
Appendix
Available only for authorised users
Literature
1.
go back to reference American Cancer Society. Cancer treatment & survivorship facts & figures 2019–2021. Atlanta: American Cancer Society; 2019. American Cancer Society. Cancer treatment & survivorship facts & figures 2019–2021. Atlanta: American Cancer Society; 2019.
2.
go back to reference Götze H, et al. Comorbid conditions and health-related quality of life in long-term cancer survivors-associations with demographic and medical characteristics. J Cancer Surviv. 2018;12(5):712–20.PubMedCrossRef Götze H, et al. Comorbid conditions and health-related quality of life in long-term cancer survivors-associations with demographic and medical characteristics. J Cancer Surviv. 2018;12(5):712–20.PubMedCrossRef
3.
go back to reference Cavers D, et al. Living with and beyond cancer with comorbid illness: a qualitative systematic review and evidence synthesis. J Cancer Surviv. 2019;13(1):148–59.PubMedPubMedCentralCrossRef Cavers D, et al. Living with and beyond cancer with comorbid illness: a qualitative systematic review and evidence synthesis. J Cancer Surviv. 2019;13(1):148–59.PubMedPubMedCentralCrossRef
4.
go back to reference Miroševič Š, et al. Prevalence and factors associated with unmet needs in post-treatment cancer survivors: a systematic review. Eur J Cancer Care (Engl). 2019;28(3):e13060.CrossRef Miroševič Š, et al. Prevalence and factors associated with unmet needs in post-treatment cancer survivors: a systematic review. Eur J Cancer Care (Engl). 2019;28(3):e13060.CrossRef
5.
go back to reference Lisy K, et al. Identifying the most prevalent unmet needs of cancer survivors in Australia: a systematic review. Asia Pac J Clin Oncol. 2019;15(5):E68–78.PubMedCrossRef Lisy K, et al. Identifying the most prevalent unmet needs of cancer survivors in Australia: a systematic review. Asia Pac J Clin Oncol. 2019;15(5):E68–78.PubMedCrossRef
6.
go back to reference Shakeel S, et al. Evaluation of factors associated with unmet needs in adult cancer survivors in Canada. Jama Network Open 2020;3(3). Shakeel S, et al. Evaluation of factors associated with unmet needs in adult cancer survivors in Canada. Jama Network Open 2020;3(3).
7.
go back to reference Shulman LN, Sheldon LK, Benz EJ. The future of cancer care in the United States-overcoming workforce capacity limitations. JAMA Oncol. 2020;6(3):327–8.PubMedCrossRef Shulman LN, Sheldon LK, Benz EJ. The future of cancer care in the United States-overcoming workforce capacity limitations. JAMA Oncol. 2020;6(3):327–8.PubMedCrossRef
8.
go back to reference Takvorian SU, et al. Developing and sustaining an effective and resilient oncology careforce: opportunities for action. J Natl Cancer Inst. 2020;112(7):663–70.PubMedPubMedCentralCrossRef Takvorian SU, et al. Developing and sustaining an effective and resilient oncology careforce: opportunities for action. J Natl Cancer Inst. 2020;112(7):663–70.PubMedPubMedCentralCrossRef
10.
go back to reference Hewitt M, Greenfield S, Stovall E, From cancer patient to cancer survivor: lost in transition. Washington. DC: National Academies Press; 2006. Hewitt M, Greenfield S, Stovall E, From cancer patient to cancer survivor: lost in transition. Washington. DC: National Academies Press; 2006.
11.
12.
go back to reference Jacobsen PB, et al. Identification of key gaps in cancer survivorship research: findings from the American Society of Clinical Oncology Survey. Journal of Oncology Practice. 2016;12(3):190–3.PubMedCrossRef Jacobsen PB, et al. Identification of key gaps in cancer survivorship research: findings from the American Society of Clinical Oncology Survey. Journal of Oncology Practice. 2016;12(3):190–3.PubMedCrossRef
13.
go back to reference Kline RM, et al. Long-term survivorship care after cancer treatment - summary of a 2017 national cancer policy forum workshop. J Natl Cancer Inst. 2018;110(12):1300–10.PubMedPubMedCentralCrossRef Kline RM, et al. Long-term survivorship care after cancer treatment - summary of a 2017 national cancer policy forum workshop. J Natl Cancer Inst. 2018;110(12):1300–10.PubMedPubMedCentralCrossRef
14.
go back to reference Lerro CC, et al. A systematic review of large-scale surveys of cancer survivors conducted in North America, 2000–2011. J Cancer Surviv. 2012;6(2):115–45.PubMedCrossRef Lerro CC, et al. A systematic review of large-scale surveys of cancer survivors conducted in North America, 2000–2011. J Cancer Surviv. 2012;6(2):115–45.PubMedCrossRef
15.
go back to reference Burris JL, Andrykowski MA. Physical and mental health status and health behaviors of survivors of multiple cancers: a national, population-based study. Ann Behav Med. 2011;42(3):304–12.PubMedCrossRef Burris JL, Andrykowski MA. Physical and mental health status and health behaviors of survivors of multiple cancers: a national, population-based study. Ann Behav Med. 2011;42(3):304–12.PubMedCrossRef
16.
17.
go back to reference Nelson DE, et al. The health information national trends survey (HINTS): development, design, and dissemination. J Health Commun. 2004;9(5):443–60; discussion 81–4. Nelson DE, et al. The health information national trends survey (HINTS): development, design, and dissemination. J Health Commun. 2004;9(5):443–60; discussion 81–4.
18.
go back to reference Short PF, Moran JR, Punekar R. Medical expenditures of adult cancer survivors aged <65 years in the United States. Cancer. 2011;117(12):2791–800.PubMedCrossRef Short PF, Moran JR, Punekar R. Medical expenditures of adult cancer survivors aged <65 years in the United States. Cancer. 2011;117(12):2791–800.PubMedCrossRef
19.
go back to reference Smith WA, et al. Physical activity among cancer survivors and those with no history of cancer- a report from the National Health and Nutrition Examination Survey 2003–2006. Am J Transl Res. 2011;3(4):342–50.PubMedPubMedCentral Smith WA, et al. Physical activity among cancer survivors and those with no history of cancer- a report from the National Health and Nutrition Examination Survey 2003–2006. Am J Transl Res. 2011;3(4):342–50.PubMedPubMedCentral
20.
24.
go back to reference Ambs A, et al. Overview of the SEER–Medicare Health Outcomes Survey linked dataset. Health Care Financ Rev. 2008;29(4):5–21.PubMedPubMedCentral Ambs A, et al. Overview of the SEER–Medicare Health Outcomes Survey linked dataset. Health Care Financ Rev. 2008;29(4):5–21.PubMedPubMedCentral
25.
go back to reference Leach CR, et al. Preparedness and cancer-related symptom management among cancer survivors in the first year post-treatment. Ann Behav Med. 2017;51(4):587–98.PubMedCrossRef Leach CR, et al. Preparedness and cancer-related symptom management among cancer survivors in the first year post-treatment. Ann Behav Med. 2017;51(4):587–98.PubMedCrossRef
26.
go back to reference Parikh-Patel A, et al. Validation of self-reported cancers in the California Teachers Study. Am J Epidemiol. 2003;157(6):539–45.PubMedCrossRef Parikh-Patel A, et al. Validation of self-reported cancers in the California Teachers Study. Am J Epidemiol. 2003;157(6):539–45.PubMedCrossRef
28.
go back to reference Pakiz B, et al. Correlates of quality of life in overweight or obese breast cancer survivors at enrollment into a weight loss trial. Psychooncology. 2016;25(2):142–9.PubMedCrossRef Pakiz B, et al. Correlates of quality of life in overweight or obese breast cancer survivors at enrollment into a weight loss trial. Psychooncology. 2016;25(2):142–9.PubMedCrossRef
29.
go back to reference Wallner LP, et al. Involvement of primary care physicians in the decision making and care of patients with breast cancer. J Clin Oncol. 2016;34(33):3969–75.PubMedPubMedCentralCrossRef Wallner LP, et al. Involvement of primary care physicians in the decision making and care of patients with breast cancer. J Clin Oncol. 2016;34(33):3969–75.PubMedPubMedCentralCrossRef
31.
go back to reference Ulrich CM, et al. The ColoCare Study: a paradigm of transdisciplinary science in colorectal cancer outcomes. Cancer Epidemiol Biomarkers Prev. 2019;28(3):591–601.PubMedCrossRef Ulrich CM, et al. The ColoCare Study: a paradigm of transdisciplinary science in colorectal cancer outcomes. Cancer Epidemiol Biomarkers Prev. 2019;28(3):591–601.PubMedCrossRef
33.
go back to reference Staton AD, et al. Next-generation prognostic assessment for diffuse large B-cell lymphoma. Future Oncol. 2015;11(17):2443–57.PubMedCrossRef Staton AD, et al. Next-generation prognostic assessment for diffuse large B-cell lymphoma. Future Oncol. 2015;11(17):2443–57.PubMedCrossRef
34.
go back to reference Cerhan JR, et al. Cohort profile: the lymphoma specialized program of research excellence (SPORE) molecular epidemiology resource (MER) cohort study. Int J Epidemiol. 2017;46(6):1753–1754i.PubMedPubMedCentralCrossRef Cerhan JR, et al. Cohort profile: the lymphoma specialized program of research excellence (SPORE) molecular epidemiology resource (MER) cohort study. Int J Epidemiol. 2017;46(6):1753–1754i.PubMedPubMedCentralCrossRef
35.
go back to reference Newcomb LF, et al. Canary prostate active surveillance study: design of a multi-institutional active surveillance cohort and biorepository. Urology. 2010;75(2):407–13.PubMedCrossRef Newcomb LF, et al. Canary prostate active surveillance study: design of a multi-institutional active surveillance cohort and biorepository. Urology. 2010;75(2):407–13.PubMedCrossRef
39.
go back to reference Friedman DL. The childhood cancer survivor study: an important research initiative for childhood cancer survivors. J Pediatr Oncol Nurs. 1999;16(3):172–5.PubMedCrossRef Friedman DL. The childhood cancer survivor study: an important research initiative for childhood cancer survivors. J Pediatr Oncol Nurs. 1999;16(3):172–5.PubMedCrossRef
40.
go back to reference Bacon CG, et al. The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer. J Urol. 2001;166(5):1804–10.PubMedCrossRef Bacon CG, et al. The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer. J Urol. 2001;166(5):1804–10.PubMedCrossRef
43.
go back to reference Barry M, et al. α-Methylacyl-CoA racemase expression and lethal prostate cancer in the physicians’ health study and health professionals follow-up study. Prostate. 2012;72(3):301–6.PubMedCrossRef Barry M, et al. α-Methylacyl-CoA racemase expression and lethal prostate cancer in the physicians’ health study and health professionals follow-up study. Prostate. 2012;72(3):301–6.PubMedCrossRef
45.
go back to reference Bright-Gbebry M, et al. Use of multivitamins, folic acid and herbal supplements among breast cancer survivors: the Black women’s health study. BMC Complement Altern Med. 2011;11:30.PubMedPubMedCentralCrossRef Bright-Gbebry M, et al. Use of multivitamins, folic acid and herbal supplements among breast cancer survivors: the Black women’s health study. BMC Complement Altern Med. 2011;11:30.PubMedPubMedCentralCrossRef
46.
go back to reference Kolonel LN, et al. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol. 2000;151(4):346–57.PubMedCrossRef Kolonel LN, et al. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol. 2000;151(4):346–57.PubMedCrossRef
47.
go back to reference Newcomb PA, et al. Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev. 2007;16(11):2331–43.PubMedCrossRef Newcomb PA, et al. Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev. 2007;16(11):2331–43.PubMedCrossRef
48.
50.
go back to reference The Women’s Health Initiative Study Group. Design of the women’s health initiative clinical trial and observational study. Control Clin Trials. 1998;19(1):61–109.CrossRef The Women’s Health Initiative Study Group. Design of the women’s health initiative clinical trial and observational study. Control Clin Trials. 1998;19(1):61–109.CrossRef
51.
go back to reference Anderson GL, et al. Implementation of the women’s health initiative study design. Ann Epidemiol. 2003;13(9 Suppl):S5-17.PubMedCrossRef Anderson GL, et al. Implementation of the women’s health initiative study design. Ann Epidemiol. 2003;13(9 Suppl):S5-17.PubMedCrossRef
52.
go back to reference Gallicchio L, et al. Evidence gaps in cancer survivorship care: a report from the 2019 National Cancer Institute Cancer Survivorship Workshop. J Natl Cancer Inst. 2021. Gallicchio L, et al. Evidence gaps in cancer survivorship care: a report from the 2019 National Cancer Institute Cancer Survivorship Workshop. J Natl Cancer Inst. 2021.
53.
go back to reference Nekhlyudov L, et al. Developing a quality of cancer survivorship care framework: implications for clinical care, research, and policy. J Natl Cancer Inst. 2019;111(11):1120–30.PubMedPubMedCentralCrossRef Nekhlyudov L, et al. Developing a quality of cancer survivorship care framework: implications for clinical care, research, and policy. J Natl Cancer Inst. 2019;111(11):1120–30.PubMedPubMedCentralCrossRef
54.
go back to reference Clarke SP, Cossette S. Secondary analysis: theoretical, methodological, and practical considerations. Can J Nurs Res. 2000;32(3):109–29 PMID: 11928128.PubMed Clarke SP, Cossette S. Secondary analysis: theoretical, methodological, and practical considerations. Can J Nurs Res. 2000;32(3):109–29 PMID: 11928128.PubMed
Metadata
Title
Large-scale North American cancer survivorship surveys: 2011–2019 update
Authors
Ahrang Jung
Shelley S. Kay
Jennifer L. Robinson
Bonny Bloodgood Sheppard
Deborah K. Mayer
Publication date
04-11-2021
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 6/2022
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-021-01111-w

Other articles of this Issue 6/2022

Journal of Cancer Survivorship 6/2022 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine